CTI Clinical Trial and Consulting Services

General information

CTI Clinical Trial and Consulting Services
Schillerstrasse 1/15
89077 Ulm, Baden-Württemberg
Germany

Contact person: Christiane Alexander, Business Development & Client Management
Company main phone: +49 (731) 4000840
Website: https://www.ctifacts.com

Year founded:	1999
Source of foundation:	Subsidiary
Name of foundation source:	CTI Clinical Trial and Consulting Services, USA
No. of employees:	Worldwide: 1000 At this location: 200

Corporate description / mission:
CTI Clinical Trial and Consulting Services provides drug development services. CTI is conducting clinical trials with life-changing therapies in chronically and critically ill patient populations. The company offers clinical trials, drug and device development, medical education, healthcare communication, early phase development, and health outcomes research.

State of ownership: Private / independent
Headquarters: HQ: No

Categorization

Sector:

Professional Services and Consulting

Subsector:

Drug development consulting

Business model:

Research on contract basis
Service company
Subsidiary

Customer segments:

Large biotech & big pharma
Large medtech
Small biotech
Small medtech

Distribution:

Direct (own sales force)

Summary Products / Services / Technologies

Description of products:
Regulatory consulting,
Clinical trial services PhI-IV,
Lab services,
CRC - phase I unit,
RWE services, market access, HTA.

Collaborations & Clients

Client portfolio (as relevant):
CTI is currently working on behalf of more than 200 sponsors from the biotech, pharma and medtech industry based in Europe, US, Asia-Pacific, and Latin America. CTI has successfully been a part of more than 100 new drug and device approvals through global regulatory agencies such as the FDA, EMA, and others, and has conducted more than 6000 successful, innovative and cost-effective projects.